There was no enrichment of any of the three gene signatures according to the tumor PR status; and only the proliferation signature showed any significant relationship to the ERBB2 status, with these proliferation genes more highly expressed in the ERBB2-positive breast cancer cases (nominal P = 0.01; adjusted for multiple comparisons P = 0.02). The gene discussed is PGR; the disease is breast cancer.